The French regulator, ANSM, has imposed fines totaling almost €8m ($9m) on 11 pharmaceutical companies for failing to meet their obligations to hold a minimum of four months’ stock of certain medicines of “major therapeutic interest” (MMTIs).
The fines, which are part of a government drive to prevent and address shortages of key drugs, show a sharp...








